News | February 02, 2015

Abbott’s High Sensitive Troponin Test May Double Diagnosis of Women’s Myocardial Infarction

Test features gender-specific cutoffs, may reduce evaluation time by several hours

Abbott, troponin, women, myocardial infarction, blood testing, diagnosis

February 2, 2015 — The British Medical Journal published results online that show Abbott’s Architect Stat High Sensitive Troponin-I (hsTnl) test may help doctors to detect twice as many myocardial infarctions (MI) in women. Results showed that Abbott’s test was able to diagnose MI in 22 percent of cases for women compared to a standard of 11 percent, when using a sex-specific threshold.

The study was funded by a special project grant from the British Heart Foundation. It was conducted by researchers at the University of Edinburgh and collected data from 1,126 patients to evaluate the use of Abbott’s test in diagnosing MI.

Abbott’s test can precisely measure very low levels of cardiac troponin, a protein which at increased levels can indicate injury to the heart. This is especially important for women, who often have lower levels of troponin than men. As a result, some women may have their heart attacks undetected and undiagnosed. These factors, as well as others, contribute to inequalities in the diagnosis and treatment of women.

“Women are likely to have poorer outcomes following a heart attack compared to men of the same age,” said Anoop Shah, M.D., one of the study authors from the University of Edinburgh. “While men and women are just as likely to present to the emergency department with chest pain, men are currently twice as likely to be diagnosed with a heart attack. The high sensitive troponin test, with gender specific thresholds for men and women, may diagnose more heart attacks in women, and identify women at high risk who may benefit from targeted evidence based therapy.”

The National Institute for Health and Care Excellence (NICE) recommended Abbott’s hsTnl test, among others, in October 2014 to help doctors quickly rule out heart attacks in NHS emergency departments in England and Wales. By using Abbott’s hsTnI test, doctors may reduce the time for evaluating heart attacks by several hours compared to standard troponin tests. Among the tests included in this guidance, only Abbott’s hsTnI test offers gender specific cutoffs.

Abbott’s hsTnI test is commercially available in in Europe, as well as Canada, Australia, New Zealand, and Brazil. The test runs on Abbott’s fully automated Architect family of analyzers.

For more information: www.bmj.com

 

Related Content

NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
PURE study may cause revision of fat intake guidelines for cardiology.
Feature | ESC| September 07, 2017
September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of
Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Advances in FFR, FFR-CT, was the most popular cardiology story in August 2017.

The most popular article in August was about advances in fractional flow reserve (FFR) technologies. The image shows Philips' new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions.

Feature | September 01, 2017 | Dave Fornell
September 1, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional Car
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG| August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
Overlay Init